MedPath
FDA Approval

Arsenic trioxide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 5, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Arsenic trioxide(1 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Zydus Lifesciences Limited

650348852

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zydus Lifesciences Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited

650348852

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Arsenic trioxide

Product Details

NDC Product Code
49315-005
Application Number
ANDA206228
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
November 5, 2022
Code: S7V92P67HOClass: ACTIBQuantity: 1 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath